fep blue glp 1 coverage 2025 KFF on X: "Among the largest employers (with at least 5,000 workers), 43% now cover GLP-1 weight-loss drugs, up from 28% last year. A majority (59%) of those same employers say their KFF's survey of Medicaid officials

Scientists have also learned how to develop synthetic peptides (lab made versions), which have been designed to mimic or enhance these natural functions in the body

It works by supporting the bodys natural signaling related to growth hormone pathways (rather than replacing growth hormone directly)

When patients are prescribed semaglutide treatments by their licensed healthcare professional or a telehealth provider, they are entitled to receive authentic, FDA-approved and regulated Wegovy," said Dave Moore, Executive Vice President, US Operations of Novo Nordisk, in a statement

Growth hormone secretagogues like CJC-1295 and Ipamorelin work through the former mechanism